Dalteparin sodium is a low molecular weight heparin (LMWH) medication used to manage venous thromboembolism (VTE), deep vein thrombosis (DVT), and ischemic complications of unstable angina and non-Q-wave myocardial infarction. The medication is derived from unfractionated heparin to form LMWH and is commonly administered as a subcutaneous injection. Symptoms of overdose necessitate urgent medical attention, with protamine sulfate as an antidote. Routine complete blood counts and stool occult blood tests are recommended during treatment with dalteparin, and patients with renal insufficiency require additional monitoring. Concomitant use of medications that affect coagulation may pose similar risks as other heparins.
Copyright © 2025, StatPearls Publishing LLC.